Skip to content

PRLDPRELUDE THERAPEUTICS INC

CUSIP 74065P101 · common stock

2 tracked investors held PRELUDE THERAPEUTICS INC (PRLD) at the end of Q3 2026, worth $64.9M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. Adar1 Capital Management sold out of its position this quarter.

Holders · Q3 2026
2
New holders
0
Value held
$64.9M
Quarter-end price (est.)
$3.91

Investors holding PRLD · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.19%10,123,824$39.6MHOLD
RA Capital Management
RA Capital Management, L.P.
0.25%6,475,882$25.3MHOLD

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Adar1 Capital Management0.22%900,900$4.8MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026201$64.9M$3.91
Q2 2026310$93.3M$5.33
Q1 2026210$35.1M$3.42
Q4 2025100$29.4M$2.90